Farmacogenómica de etanercept, infliximab, adalimumab y metotrexato en artritis reumatoide. Revisión estructurada-Reference-Cited by-同舟云学术

Farmacogenómica de etanercept, infliximab, adalimumab y metotrexato en artritis reumatoide. Revisión estructurada

Published:2018-01 Issue:1 Volume:25 Page:22-37
ISSN:0121-8123
Container-title:Revista Colombiana de Reumatología
language:es
Short-container-title:Revista Colombiana de Reumatología

Author:

Puentes Osorio Yolima,Amariles Pedro,Aristizábal Bernal Beatriz Helena,Pinto Peñaranda Luis Fernando,Calleja Hernández Miguel Ángel

Publisher

Elsevier BV

Subject

Rheumatology

Reference51 articles.

1. Using genetic diagnosis to determine individual therapeutic utility;Caskey;Annu Rev Med.,2010

2. Sequencing the entire genomes of free-living organisms: The foundation of pharmacology in the new millennium;Broder;Annu Rev Pharmacol Toxicol.,2000

3. Genetic Alliance; The New York-Mid-Atlantic Consortium for Genetic and Newborn Screening Services. Understanding Genetics: A New York, Mid-Atlantic Guide for Patients and Health Professionals. Washington (DC): Genetic Alliance; 2009 Jul 8. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK115563/

4. Howard L McLeod, William E Evans. Pharmacogenomics: Unlocking the Human Genome for Better Drug Therapy. Department of Medicine, Division of Oncology, Washington University Medical School, St. Louis, Missouri. Annual Review of Pharmacology and Toxicology. Vol. 41: 101-121 (Volume publication date April 2001) DOI: 10.1146/annurev.pharmtox.41.1.101

5. Pharmacogenetics of cancer drugs;Hertz;Annu Rev Med.,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms of FcGR2B and adalimumab effectiveness in Colombian patients with rheumatoid arthritis. Cases-controls study;2022-09-21

2. Potential clinical biomarkers in rheumatoid arthritis with an omic approach;Autoimmunity Highlights;2021-05-31

3. Drug-resistance in rheumatoid arthritis: the role of p53 gene mutations, ABC family transporters and personal factors;Current Opinion in Pharmacology;2020-10